2024 Q4 Form 10-Q Financial Statement

#000165495424014466 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $4.696M
YoY Change -1.4%
Cost Of Revenue $2.515M
YoY Change 9.51%
Gross Profit $2.181M
YoY Change -11.56%
Gross Profit Margin 46.44%
Selling, General & Admin $1.818M
YoY Change 11.11%
% of Gross Profit 83.36%
Research & Development $771.3K
YoY Change 6.31%
% of Gross Profit 35.37%
Depreciation & Amortization $775.0K
YoY Change 15.66%
% of Gross Profit 35.54%
Operating Expenses $2.589M
YoY Change 9.64%
Operating Profit -$408.4K
YoY Change -492.14%
Interest Expense $76.00
YoY Change -99.62%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$440.2K
YoY Change -447.23%
Income Tax $738.00
% Of Pretax Income
Net Earnings -$440.9K
YoY Change -449.85%
Net Earnings / Revenue -9.39%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 90.48M shares 90.48M shares
Diluted Shares Outstanding 90.48M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $291.2K
YoY Change -64.49%
Cash & Equivalents $291.2K
Short-Term Investments
Other Short-Term Assets $151.7K
YoY Change 75.01%
Inventory
Prepaid Expenses $211.7K
Receivables $1.077M
Other Receivables $0.00
Total Short-Term Assets $1.732M
YoY Change -17.4%
LONG-TERM ASSETS
Property, Plant & Equipment $235.3K
YoY Change -95.02%
Goodwill $110.0K
YoY Change 0.0%
Intangibles $53.97K
YoY Change -20.18%
Long-Term Investments
YoY Change
Other Assets $17.54K
YoY Change -12.3%
Total Long-Term Assets $5.658M
YoY Change 5.38%
TOTAL ASSETS
Total Short-Term Assets $1.732M
Total Long-Term Assets $5.658M
Total Assets $7.390M
YoY Change -1.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.849M
YoY Change 29.48%
Accrued Expenses $186.0K
YoY Change -7.01%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.062M
YoY Change 24.17%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change -100.0%
Other Long-Term Liabilities $311.1K
YoY Change -49.0%
Total Long-Term Liabilities $311.1K
YoY Change -76.43%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.062M
Total Long-Term Liabilities $311.1K
Total Liabilities $5.373M
YoY Change -0.49%
SHAREHOLDERS EQUITY
Retained Earnings -$20.58M
YoY Change 3.37%
Common Stock $90.48K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.017M
YoY Change
Total Liabilities & Shareholders Equity $7.390M
YoY Change -1.02%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$440.9K
YoY Change -449.85%
Depreciation, Depletion And Amortization $775.0K
YoY Change 15.66%
Cash From Operating Activities $973.2K
YoY Change 4.65%
INVESTING ACTIVITIES
Capital Expenditures $914.7K
YoY Change 7.62%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$914.7K
YoY Change 7.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities 973.2K
Cash From Investing Activities -914.7K
Cash From Financing Activities
Net Change In Cash 58.49K
YoY Change -26.89%
FREE CASH FLOW
Cash From Operating Activities $973.2K
Capital Expenditures $914.7K
Free Cash Flow $58.49K
YoY Change -26.89%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90477798 shares
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
126036 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 qmci Convertible Preferred Stock Designated
ConvertiblePreferredStockDesignated
550000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
90477798 shares
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
525000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
323150 usd
CY2023Q3 qmci Earningspersharebasic
Earningspersharebasic
0.00
dei Entity Central Index Key
EntityCentralIndexKey
0001101433
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Security12b Title
Security12bTitle
Common stock, par value $.001 per share
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
90477798 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
90477798 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
90477798 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
123685 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
123685 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
123685 shares
CY2023Q4 qmci Convertible Preferred Stock Designated
ConvertiblePreferredStockDesignated
550000 shares
qmci Expected Dividend Yield
ExpectedDividendYield
0 pure
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-28599
dei Entity Registrant Name
EntityRegistrantName
QuoteMedia, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
91-2008633
dei Entity Address Address Line1
EntityAddressAddressLine1
17100 East Shea Boulevard
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 230
dei Entity Address City Or Town
EntityAddressCityOrTown
Fountain Hills
dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85268
dei City Area Code
CityAreaCode
602
dei Local Phone Number
LocalPhoneNumber
830-1443
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
90477798 shares
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
291217 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
342014 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1077493 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1154787 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
211748 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
133478 usd
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
151745 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
104931 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
1732203 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1735210 usd
CY2024Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
17539 usd
CY2023Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
16850 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
235336 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
302224 usd
CY2024Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
5001877 usd
CY2023Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
4552910 usd
CY2024Q3 us-gaap Goodwill
Goodwill
110000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
110000 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
53974 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
65636 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
239462 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
393472 usd
CY2024Q3 us-gaap Assets
Assets
7390391 usd
CY2023Q4 us-gaap Assets
Assets
7176302 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2848533 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2210933 usd
CY2024Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2027800 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1456381 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
185989 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
206146 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5062322 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3873460 usd
CY2024Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
256864 usd
CY2023Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
375568 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
54206 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
191735 usd
CY2024Q3 qmci Preferred Stock Warrant Liability
PreferredStockWarrantLiability
0 usd
CY2023Q4 qmci Preferred Stock Warrant Liability
PreferredStockWarrantLiability
611563 usd
CY2024Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
311070 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1178866 usd
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
123685 shares
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
2983857 usd
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
90479 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
90479 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
19523795 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18910482 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-20581132 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19860842 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
2016999 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-859881 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7390391 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7176302 usd
CY2024Q3 us-gaap Revenues
Revenues
4695845 usd
CY2023Q3 us-gaap Revenues
Revenues
4762442 usd
us-gaap Revenues
Revenues
14050991 usd
us-gaap Revenues
Revenues
14225467 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
2515081 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
2296736 usd
us-gaap Cost Of Revenue
CostOfRevenue
7288655 usd
us-gaap Cost Of Revenue
CostOfRevenue
6941469 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
2180764 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
2465706 usd
us-gaap Gross Profit
GrossProfit
6762336 usd
us-gaap Gross Profit
GrossProfit
7283998 usd
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
875303 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
711861 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2510029 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2365626 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
942598 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
924249 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2611279 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2546950 usd
CY2024Q3 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
771261 usd
CY2023Q3 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
725449 usd
us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
2361657 usd
us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
2039537 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-408398 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
104147 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-720629 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
331885 usd
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-31881 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
21803 usd
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
3841 usd
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-16271 usd
CY2024Q3 us-gaap Interest Expense
InterestExpense
76 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
825 usd
us-gaap Interest Expense
InterestExpense
1296 usd
us-gaap Interest Expense
InterestExpense
1031 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-440203 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
126775 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-718084 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
314583 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
738 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
739 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2206 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2221 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-440941 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
126036 usd
us-gaap Net Income Loss
NetIncomeLoss
-720290 usd
us-gaap Net Income Loss
NetIncomeLoss
312362 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90477798 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90477798 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90477798 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90477798 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
90477798 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
121479248 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
90477798 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
121103306 shares
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
2457940 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-440941 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
2016999 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-859881 usd
qmci Reclassification Of Preferred Stock Warrants
ReclassificationOfPreferredStockWarrants
611563 usd
qmci Reclassification Of Series A Redeemable Convertible Preferred Stock Amount
ReclassificationOfSeriesARedeemableConvertiblePreferredStockAmount
2983857 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1750 usd
us-gaap Net Income Loss
NetIncomeLoss
-720290 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
2016999 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1042349 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-916313 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1228675 usd
us-gaap Net Income Loss
NetIncomeLoss
312362 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-916313 usd
us-gaap Profit Loss
ProfitLoss
-720290 usd
us-gaap Profit Loss
ProfitLoss
312362 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2255707 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1944271 usd
qmci Allowance For Doubtful Accounts
AllowanceForDoubtfulAccounts
525000 usd
qmci Allowance For Doubtful Accounts
AllowanceForDoubtfulAccounts
275000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1750 usd
us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
qmci Stock Based Compensation Preferred Stock
StockBasedCompensationPreferredStock
0 usd
qmci Stock Based Compensation Preferred Stock
StockBasedCompensationPreferredStock
80625 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-447706 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-575133 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-78270 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-52764 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-46814 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-57615 usd
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
-689 usd
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
-5179 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
633924 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-184670 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
452715 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1065078 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2575327 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2801975 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
34374 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
71249 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
2591750 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
2387774 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2626124 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2459023 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-50797 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
342952 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
342014 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
477987 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
291217 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
820939 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
225000 usd
CY2024Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
182171 usd
CY2023Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
155980 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
117739 usd
CY2024Q3 us-gaap Revenues
Revenues
4695845 usd
CY2023Q3 us-gaap Revenues
Revenues
4762442 usd
us-gaap Revenues
Revenues
14050991 usd
us-gaap Revenues
Revenues
14225467 usd
qmci Deferred Revenue At Beginning Balance
DeferredRevenueAtBeginningBalance
1831949 usd
qmci Deferred Revenue At Beginning Balance
DeferredRevenueAtBeginningBalance
1166848 usd
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
1374128 usd
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
995364 usd
us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
1805620 usd
us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
1873614 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
21223 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
4566 usd
qmci Deferred Revenue At Ending Balance
DeferredRevenueAtEndingBalance
2284664 usd
qmci Deferred Revenue At Ending Balance
DeferredRevenueAtEndingBalance
2049664 usd
CY2024Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2027800 usd
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1676949 usd
CY2024Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
256864 usd
CY2023Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
372715 usd
CY2024Q3 us-gaap Deferred Revenue
DeferredRevenue
2284664 usd
CY2023Q3 us-gaap Deferred Revenue
DeferredRevenue
2049664 usd
us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
lease terms of 1 year to 3 years
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
239462 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
393472 usd
CY2024Q3 qmci Current Portion Of Operating Lease Liability
CurrentPortionOfOperatingLeaseLiability
185989 usd
CY2023Q4 qmci Current Portion Of Operating Lease Liability
CurrentPortionOfOperatingLeaseLiability
206146 usd
CY2024Q3 qmci Long Term Portion Of Operating Lease Liability
LongTermPortionOfOperatingLeaseLiability
54206 usd
CY2023Q4 qmci Long Term Portion Of Operating Lease Liability
LongTermPortionOfOperatingLeaseLiability
191735 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
240195 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
397881 usd
qmci Operating Lease Weighted Average Remaining Lease Term
OperatingLeaseWeightedAverageRemainingLeaseTerm
P1Y3M18D
CY2023 qmci Operating Lease Weighted Average Remaining Lease Term
OperatingLeaseWeightedAverageRemainingLeaseTerm
P1Y10M24D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.094 pure
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.095 pure
CY2024Q3 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
56454 usd
CY2024Q3 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
165073 usd
CY2024Q3 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
34117 usd
CY2024Q3 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
255644 usd
CY2024Q3 qmci Less Imputed Interest Operating
LessImputedInterestOperating
-15449 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
240195 usd
CY2024Q3 us-gaap Operating Lease Initial Direct Cost Expense Over Term
OperatingLeaseInitialDirectCostExpenseOverTerm
59042 usd
CY2023Q3 us-gaap Operating Lease Initial Direct Cost Expense Over Term
OperatingLeaseInitialDirectCostExpenseOverTerm
58504 usd
us-gaap Operating Lease Initial Direct Cost Expense Over Term
OperatingLeaseInitialDirectCostExpenseOverTerm
177052 usd
us-gaap Operating Lease Initial Direct Cost Expense Over Term
OperatingLeaseInitialDirectCostExpenseOverTerm
176096 usd
CY2024Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
27450 usd
CY2023Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
27111 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
82125 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
81091 usd
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
86492 usd
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
85615 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
259177 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
257187 usd
qmci Operating Cash Flows From Operating Leases
OperatingCashFlowsFromOperatingLeases
173720 usd
qmci Operating Cash Flows From Operating Leases
OperatingCashFlowsFromOperatingLeases
172454 usd
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q3 us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
0 usd
CY2023Q3 us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
57188 usd
us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
1750 usd
us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
80625 usd
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
57188 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1750 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
80625 usd
qmci Expected Stock Price Volatility
ExpectedStockPriceVolatility
0.76 pure
qmci Risk Free Interest Rate
RiskFreeInterestRate
0.04 pure
qmci Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Term
ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm
P2Y6M
qmci Weighted Average Fair Value Of Options And Warrants Granted
WeightedAverageFairValueOfOptionsAndWarrantsGranted
0.17
CY2023 qmci Expected Time To Expiration Years
ExpectedTimeToExpirationYears
P24Y18D
CY2023 qmci Stock Price On Valuation Date
StockPriceOnValuationDate
0.23
CY2023 qmci Five Year Peer Volatility
FiveYearPeerVolatility
0.4735 pure
CY2023 qmci Cash Flow Discount Rate
CashFlowDiscountRate
0.1586 pure
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-440941 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
126036 usd
us-gaap Net Income Loss
NetIncomeLoss
-720290 usd
us-gaap Net Income Loss
NetIncomeLoss
312362 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90477798 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90477798 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90477798 shares
CY2024Q3 qmci Warrants To Purchase Redeemable Convertible Preferred Stock
WarrantsToPurchaseRedeemableConvertiblePreferredStock
0 usd
CY2023Q3 qmci Warrants To Purchase Redeemable Convertible Preferred Stock
WarrantsToPurchaseRedeemableConvertiblePreferredStock
2499900 usd
qmci Warrants To Purchase Redeemable Convertible Preferred Stock
WarrantsToPurchaseRedeemableConvertiblePreferredStock
0 usd
qmci Warrants To Purchase Redeemable Convertible Preferred Stock
WarrantsToPurchaseRedeemableConvertiblePreferredStock
2499900 usd
CY2024Q3 qmci Redeemable Convertible Preferred Stock
RedeemableConvertiblePreferredStock
0 usd
CY2023Q3 qmci Redeemable Convertible Preferred Stock
RedeemableConvertiblePreferredStock
10306671 usd
qmci Redeemable Convertible Preferred Stock
RedeemableConvertiblePreferredStock
0 usd
qmci Redeemable Convertible Preferred Stock
RedeemableConvertiblePreferredStock
10306671 usd
CY2023Q3 qmci Stock Options And Warrants To Purchase Common Stock
StockOptionsAndWarrantsToPurchaseCommonStock
18194879 shares
qmci Stock Options And Warrants To Purchase Common Stock
StockOptionsAndWarrantsToPurchaseCommonStock
17818937 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
90477798 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
121479248 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
90477798 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
121103306 shares
CY2024Q3 qmci Earningspersharebasic
Earningspersharebasic
-0.00
qmci Earningspersharebasic
Earningspersharebasic
-0.00
qmci Earningspersharebasic
Earningspersharebasic
0.00
CY2024Q3 qmci Earningspersharediluted
Earningspersharediluted
-0.00
CY2023Q3 qmci Earningspersharediluted
Earningspersharediluted
0.00
qmci Earningspersharediluted
Earningspersharediluted
-0.00
qmci Earningspersharediluted
Earningspersharediluted
0.00
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
28865935 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
29203675 shares

Files In Submission

Name View Source Status
0001654954-24-014466-index-headers.html Edgar Link pending
0001654954-24-014466-index.html Edgar Link pending
0001654954-24-014466.txt Edgar Link pending
0001654954-24-014466-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
qmci-20240930.xsd Edgar Link pending
qmci_10q.htm Edgar Link pending
qmci_ex311.htm Edgar Link pending
qmci-20240930_cal.xml Edgar Link unprocessable
qmci-20240930_def.xml Edgar Link unprocessable
qmci-20240930_lab.xml Edgar Link unprocessable
qmci-20240930_pre.xml Edgar Link unprocessable
qmci_10q_htm.xml Edgar Link completed
qmci_ex312.htm Edgar Link pending
qmci_ex321.htm Edgar Link pending
qmci_ex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable